by Prostate Cancer Center | Jan 11, 2018 | Prostate Cancer
Multi-Institutional Study- SUNNYVALE, Calif., Sept. 27, 2016 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, 21 center study showed 97 percent of low- and intermediate-risk prostate cancer patients had excellent...
Recent Comments